Among patients with BTC, FGFR2 fusions/rearrangements are found almost exclusively in ICC (accounting for 10%-15%) compared with extrahepatic cholangiocarcinoma [87]. Here, FGFR2 is linked to intrahepatic cholangiocarcinoma.